Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Mycophenolate mofetil/prednisone/tacrolimus

Multiple congenital anomalies following in utero exposure?: case report

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Jackson PY, Paquette L, Watiker V, Ramanathan R, Seri I.Mycophenolate mofetil use during pregnancy and multiple congenital anomalies in a newborn infant: possible teratogenic effect. 2008 Annual Meeting of the Pediatric Academic Societies: abstr. 403, 2 May 2008. Available from: URL: http://pediatrics.hawaiiconvention.com - USA

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Mycophenolate mofetil/prednisone/tacrolimus. React. Wkly. 1204, 23 (2008). https://doi.org/10.2165/00128415-200812040-00078

    Download citation

    Keywords

    • Folic Acid
    • Tacrolimus
    • Congenital Heart Disease
    • Mycophenolate Mofetil
    • Undergo Liver Transplantation